Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ATNX

Athenex (ATNX) Stock Price, News & Analysis

Athenex logo

About Athenex Stock (NASDAQ:ATNX)

Key Stats

Today's Range
N/A
50-Day Range
$0.20
$1.52
52-Week Range
N/A
Volume
1.88 million shs
Average Volume
194,316 shs
Market Capitalization
$1.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ATNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Athenex and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ATNX Stock News Headlines

Arizona-made nanochips the new millionaire maker?
George Gilder handed President Reagan the first microchip that helped create $6.5 trillion in wealth over the last 40 years. Now he's stepping forward with an even bigger prediction about what's being built in the Arizona desert. He believes 3 little-known companies will explode when a bombshell announcement just days from now. Smart investors are already positioning themselves.tc pixel
Athenex (NASDAQ: ATNX)
See More Headlines

ATNX Stock Analysis - Frequently Asked Questions

Athenex, Inc. (NASDAQ:ATNX) released its quarterly earnings data on Thursday, November, 4th. The company reported ($0.33) EPS for the quarter, topping the consensus estimate of ($0.41) by $0.08. The company had revenue of $32.30 million for the quarter, compared to the consensus estimate of $19.40 million. Athenex had a negative trailing twelve-month return on equity of 727.79% and a negative net margin of 86.31%.

Athenex (ATNX) raised $72 million in an initial public offering (IPO) on Wednesday, June 14th 2017. The company issued 6,000,000 shares at $11.00-$13.00 per share. Credit Suisse, Deutsche, Bank Securities and J.P. Morgan served as the underwriters for the IPO and ICBC International was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Athenex investors own include TherapeuticsMD (TXMD), Meta Platforms (META), Sorrento Therapeutics (SRNE), NIO (NIO), NVIDIA (NVDA), Tesla (TSLA) and Ford Motor (F).

Company Calendar

Last Earnings
11/04/2021
Today
10/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ATNX
CIK
1300699
Fax
N/A
Employees
652
Year Founded
2003

Profitability

EPS (Trailing Twelve Months)
($15.88)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$103.43 million
Net Margins
-86.31%
Pretax Margin
-95.92%
Return on Equity
-727.79%
Return on Assets
-44.44%

Debt

Debt-to-Equity Ratio
3.08
Current Ratio
1.09
Quick Ratio
0.72

Sales & Book Value

Annual Sales
$102.82 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($3.07) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
8,660,000
Free Float
7,866,000
Market Cap
$1.76 million
Optionable
Optionable
Beta
1.36

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:ATNX) was last updated on 10/6/2025 by MarketBeat.com Staff
From Our Partners